Talaromyces marneffei
Species of fungus
Talaromyces marneffei, formerly known as Penicillium marneffei, is a dimorphic fungus endemic to Southeast Asia. It is a significant opportunistic pathogen in immunocompromised individuals, particularly those with HIV/AIDS.
Morphology[edit | edit source]
Talaromyces marneffei exhibits dimorphism, meaning it can exist in two different forms depending on the temperature. At 25°C, it grows as a mold, producing characteristic greenish colonies with a red pigment that diffuses into the medium. At 37°C, it converts to a yeast-like form, which is the pathogenic form in humans.
Pathogenesis[edit | edit source]
Talaromyces marneffei infection, known as talaromycosis, occurs primarily in individuals with weakened immune systems. The fungus is inhaled as spores, which then convert to the yeast form in the body, leading to systemic infection. Symptoms include fever, weight loss, and respiratory issues, often resembling tuberculosis or histoplasmosis.
Diagnosis[edit | edit source]
Diagnosis of Talaromyces marneffei infection is typically made through culture of the organism from clinical specimens such as blood, bone marrow, or skin lesions. Microscopic examination can reveal the characteristic yeast cells with transverse septa.
Treatment[edit | edit source]
The treatment of choice for talaromycosis is amphotericin B, followed by itraconazole for maintenance therapy. Early diagnosis and treatment are crucial to prevent severe complications and mortality.
Epidemiology[edit | edit source]
Talaromyces marneffei is endemic to regions of Southeast Asia, including Thailand, Vietnam, and southern China. It is associated with bamboo rat habitats, although the exact ecological niche and mode of transmission to humans remain under investigation.
Prevention[edit | edit source]
Preventive measures for talaromycosis include avoiding exposure to environments where the fungus is endemic, particularly for individuals with compromised immune systems. Prophylactic antifungal therapy may be considered for high-risk patients.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
